Skip to main content

Karuna Therapeutics, Inc.

KRTXDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001771917

Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Karuna Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Karuna Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Karuna Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Jonas Jeffrey MDirector0Mar 18, 20240
Coughlin Christopher JDirector0Mar 18, 20240
Paul Steven MDirector0IndirectMar 18, 20240
Healy JamesDirector0IndirectMar 18, 20240
Meury WilliamPresident and CEO0Mar 18, 20240
Olson Laurie JDirector0Mar 18, 20240
Pande AtulDirector0Mar 18, 20240
Brannan Stephen K.Chief Medical Officer0Mar 18, 20240
Miller Andrew CraigPresident of R&D0Mar 18, 20240
Wheadon David E.Director0Mar 18, 20240
Kane William P JrChief Commercial Officer0Mar 18, 20240
Torres DeniceDirector0Mar 18, 20240
Brown Jason ParkerChief Financial Officer0Mar 18, 20240
Ignelzi Troy A.Chief Financial Officer30,487Aug 24, 20230
Lykins CharmaineChief Commercial Officer–Nov 30, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 1, 2021 (view filing)Jul 1Same dayPande AtulDirectorSSale−2.50K$112.66−$281.6K−100.0%0 after
Jul 7, 2021 (view filing)Jul 25 daysHealy JamesDirectorPPurchase+636$117.80+$74.9KNew position636 after
Aug 2, 2021 (view filing)Aug 2Same dayPande AtulDirectorSSale−2.50K$114.17−$285.4K−100.0%0 after
Aug 18, 2021 (view filing)Aug 17-181 dayPaul Steven MPRESIDENT & CEOPPurchase+2.36K$105.86+$250.3K+2.2%108.8K after2 lots
Aug 18, 2021 (view filing)Aug 162 daysMiller Andrew CraigChief Operating OfficerSSale−5.50K$103.92−$571.6K−9.5%52.5K after3 lots
Sep 1, 2021 (view filing)Sep 1Same dayPande AtulDirectorSSale−2.50K$117.82−$294.6K−100.0%0 after
Sep 3, 2021 (view filing)Sep 1-22 daysMiller Andrew CraigChief Operating OfficerSSale−8.17K$120.78−$987.2K−15.6%44.3K after4 lots
Sep 10, 2021 (view filing)Sep 8-102 daysIgnelzi Troy A.Chief Financial OfficerSSale−10.0K$117.38−$1.17M−35.7%18.0K after4 lots
Oct 1, 2021 (view filing)Oct 1Same dayPande AtulDirectorSSale−2.50K$120.72−$301.8K−100.0%0 after
Oct 5, 2021 (view filing)Oct 1-44 daysMiller Andrew CraigChief Operating OfficerSSale−16.5K$124.36−$2.05M−37.2%27.8K after7 lots
Nov 3, 2021 (view filing)Nov 12 daysPande AtulDirectorSSale−2.50K$136.67−$341.7K−100.0%0 after
Nov 3, 2021 (view filing)Nov 12 daysBrannan Stephen K.Chief Medical OfficerSSale−7.73K$136.67−$1.06M−30.6%17.5K after2 lots
Nov 3, 2021 (view filing)Nov 12 daysMiller Andrew CraigChief Operating OfficerSSale−2.83K$142.03−$401.5K−5.2%51.5K after6 lots
Nov 10, 2021 (view filing)Nov 82 daysIgnelzi Troy A.Chief Financial OfficerSSale−13.5K$152.32−$2.06M−42.9%18.0K after
Nov 15, 2021 (view filing)Nov 15Same dayOlson Laurie JDirectorSSale−1.00K$138.24−$138.2K−100.0%0 after
Dec 2, 2021 (view filing)Dec 11 dayBrannan Stephen K.Chief Medical OfficerSSale−7.73K$127.57−$985.9K−27.9%20.0K after
Dec 2, 2021 (view filing)Dec 11 dayPande AtulDirectorSSale−2.50K$127.73−$319.3K−100.0%0 after
Jan 3, 2022 (view filing)Jan 3Same dayPande AtulDirectorSSale−2.50K$130.44−$326.1K−100.0%0 after
Jan 3, 2022 (view filing)Jan 3Same dayBrannan Stephen K.Chief Medical OfficerSSale−7.73K$130.79−$1.01M−25.6%22.5K after
Feb 2, 2022 (view filing)Feb 11 dayPande AtulDirectorSSale−2.50K$110.80−$277.0K−100.0%0 after
Feb 2, 2022 (view filing)Feb 11 dayBrannan Stephen K.Chief Medical OfficerSSale−7.73K$110.05−$850.5K−43.6%10.0K after
Feb 17, 2022 (view filing)Feb 152 daysOlson Laurie JDirectorSSale−1.00K$110.00−$110.0K−100.0%0 after
Feb 17, 2022 (view filing)Feb 152 daysIgnelzi Troy A.Chief Financial OfficerSSale−1.50K$111.14−$166.7K−5.7%25.0K after
Mar 2, 2022 (view filing)Mar 11 dayBrannan Stephen K.Chief Medical OfficerSSale−7.73K$107.38−$829.8K−38.2%12.5K after
Apr 4, 2022 (view filing)Apr 13 daysBrannan Stephen K.Chief Medical OfficerSSale−7.73K$128.45−$992.7K−34.0%15.0K after
Apr 14, 2022 (view filing)Apr 113 daysLateHealy JamesDirectorPPurchase+47$129.38+$6.08K+7.4%683 after
Apr 21, 2022 (view filing)Apr 19-212 daysIgnelzi Troy A.Chief Financial OfficerSSale−4.24K$131.24−$557.0K−14.5%25.0K after3 lots
May 9, 2022 (view filing)May 9Same dayBrannan Stephen K.Chief Medical OfficerSSale−5.00K$104.10−$520.5K−25.0%15.0K after
May 31, 2022 (view filing)May 274 daysOlson Laurie JDirectorSSale−1.00K$110.00−$110.0K−100.0%0 after
Jun 9, 2022 (view filing)Jun 9Same dayBrannan Stephen K.Chief Medical OfficerSSale−5.00K$110.90−$554.5K−25.0%15.0K after
Jul 1, 2022 (view filing)Jun 29-302 daysHealy JamesDirectorPPurchase+120.0K$122.80+$14.7M+6.1%2.07M after6 lots
Jul 11, 2022 (view filing)Jul 11Same dayBrannan Stephen K.Chief Medical OfficerSSale−15.0K$133.29−$2.00M−50.0%15.0K after
Aug 11, 2022 (view filing)Aug 92 daysIgnelzi Troy A.Chief Financial OfficerSSale−16.5K$227.83−$3.76M−39.8%25.0K after
Aug 11, 2022 (view filing)Aug 92 daysBrannan Stephen K.Chief Medical OfficerSSale−25.0K$228.08−$5.70M−62.5%15.0K after3 lots
Aug 16, 2022 (view filing)Aug 151 dayOlson Laurie JDirectorSSale−1.00K$267.59−$267.6K−100.0%0 afterFrom original
Sep 12, 2022 (view filing)Sep 93 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$243.46−$1.22M−25.0%15.0K after
Oct 4, 2022 (view filing)Sep 30-Oct 44 daysIgnelzi Troy A.Chief Financial OfficerSSale−15.0K$229.61−$3.44M−60.1%9.97K after8 lots
Oct 12, 2022 (view filing)Oct 102 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$207.51−$1.04M−25.0%15.0K after
Oct 12, 2022 (view filing)Oct 111 dayOlson Laurie JDirectorSSale−1.00K$205.63−$205.6K−100.0%0 after
Nov 3, 2022 (view filing)Nov 12 daysMiller Andrew CraigChief Operating OfficerSSale−15.0K$225.08−$3.38M−28.0%38.5K after
Nov 10, 2022 (view filing)Nov 91 dayBrannan Stephen K.Chief Medical OfficerSSale−5.00K$216.00−$1.08M−25.0%15.0K after
Nov 14, 2022 (view filing)Nov 104 daysMiller Andrew CraigChief Operating OfficerSSale−15.0K$225.98−$3.39M−37.0%25.5K after
Nov 17, 2022 (view filing)Nov 152 daysIgnelzi Troy A.Chief Financial OfficerSSale−16.5K$225.85−$3.73M−62.3%9.97K after
Dec 2, 2022 (view filing)Dec 11 dayMiller Andrew CraigChief Operating OfficerSSale−15.0K$228.30−$3.42M−57.1%11.3K after
Dec 12, 2022 (view filing)Dec 93 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$200.76−$1.00M−25.0%15.0K after2 lots
Jan 5, 2023 (view filing)Jan 32 daysOlson Laurie JDirectorSSale−1.00K$197.48−$197.5K−100.0%0 after
Jan 9, 2023 (view filing)Jan 9Same dayBrannan Stephen K.Chief Medical OfficerSSale−5.00K$197.52−$987.6K−25.0%15.0K after2 lots
Jan 17, 2023 (view filing)Jan 134 daysHealy JamesDirectorSSale−6.03K$199.90−$1.20M−100.0%0 after
Jan 19, 2023 (view filing)Jan 17-182 daysIgnelzi Troy A.Chief Financial OfficerSSale−1.02K$201.16−$204.6K−4.4%21.8K after2 lots
Feb 13, 2023 (view filing)Feb 94 daysBrannan Stephen K.Chief Medical OfficerSSale−5.00K$192.37−$961.9K−25.0%15.0K after